Literature DB >> 33445417

DNA-Damage-Induced Alternative Splicing of p53.

Jing Chen1,2, Dadong Zhang3, Xiaodi Qin3, Kouros Owzar3,4, Jennifer J McCann1, Michael B Kastan1,3.   

Abstract

Cellular responses to DNA damage and other stresses are important determinants of mutagenesis and impact the development of a wide range of human diseases. TP53 is highly mutated in human cancers and plays an essential role in stress responses and cell fate determination. A central dogma of p53 induction after DNA damage has been that the induction results from a transient increase in the half-life of the p53 protein. Our laboratory recently demonstrated that this long-standing paradigm is an incomplete picture of p53 regulation by uncovering a critical role for protein translational regulation in p53 induction after DNA damage. These investigations led to the discovery of a DNA-damage-induced alternative splicing (AS) pathway that affects p53 and other gene products. The damage-induced AS of p53 pre-mRNA generates the beta isoform of p53 (p53β) RNA and protein, which is specifically required for the induction of cellular senescence markers after ionizing irradiation (IR). In an attempt to elucidate the mechanisms behind the differential regulation and apparent functional divergence between full-length (FL) p53 and the p53β isoform (apoptosis versus senescence, respectively), we identified the differential transcriptome and protein interactome between these two proteins that may result from the unique 10-amino-acid tail in p53β protein.

Entities:  

Keywords:  aging; cancer; protein interaction; transcription

Year:  2021        PMID: 33445417      PMCID: PMC7827558          DOI: 10.3390/cancers13020251

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.575


  27 in total

1.  5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage.

Authors:  Jing Chen; Michael B Kastan
Journal:  Genes Dev       Date:  2010-09-13       Impact factor: 11.361

2.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

3.  BioID: a screen for protein-protein interactions.

Authors:  Kyle J Roux; Dae In Kim; Brian Burke
Journal:  Curr Protoc Protein Sci       Date:  2013-11-05

4.  The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.

Authors:  Kelly A Avery-Kiejda; Brianna Morten; Michelle W Wong-Brown; Andrea Mathe; Rodney J Scott
Journal:  Carcinogenesis       Date:  2013-12-11       Impact factor: 4.944

5.  Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response.

Authors:  V Marcel; K Fernandes; O Terrier; D P Lane; J-C Bourdon
Journal:  Cell Death Differ       Date:  2014-06-13       Impact factor: 15.828

6.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

7.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

Review 8.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

9.  Characterization of SMG7 14-3-3-like domain reveals phosphoserine binding-independent regulation of p53 and UPF1.

Authors:  Lauren E Cowen; Hongwei Luo; Yi Tang
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

10.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

View more
  3 in total

1.  Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.

Authors:  Luiza Steffens Reinhardt; Kira Groen; Brianna C Morten; Jean-Christophe Bourdon; Kelly A Avery-Kiejda
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

2.  A Novel Role of SMG1 in Cholesterol Homeostasis That Depends Partially on p53 Alternative Splicing.

Authors:  Muyang Li; Fredrick Philantrope; Alexandra Diot; Jean-Christophe Bourdon; Patricia Thompson
Journal:  Cancers (Basel)       Date:  2022-07-02       Impact factor: 6.575

3.  Genome-Wide RNAi Screening Identifies Novel Pathways/Genes Involved in Oxidative Stress and Repurposable Drugs to Preserve Cystic Fibrosis Airway Epithelial Cell Integrity.

Authors:  Javier Checa; Itziar Martínez-González; Maria Maqueda; Jose Luis Mosquera; Josep M Aran
Journal:  Antioxidants (Basel)       Date:  2021-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.